(Q24250316)

30 July 2017

0 references

1 reference

title

Minocycline for acne vulgaris: efficacy and safety (English)

1 reference

30 July 2017

1 reference

Anne Eady

0 references

author name string

Sarah E Garner

0 references

Catalin Mihai Popescu

0 references

John Newton

0 references

Alain Li Wan Po

0 references

S E Garner

1 reference

30 July 2017

E A Eady

1 reference

30 July 2017

C Popescu

1 reference

30 July 2017

J Newton

1 reference

30 July 2017

A Li Wan Po

1 reference

30 July 2017

W A Li

0 references

language of work or name

English

0 references

publication date

20 January 2003

0 references

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

2003

0 references

published in

1 reference

30 July 2017

1 reference

30 July 2017

0 references

page(s)

CD002086

1 reference

Efficacy of Minocycline Compared With Tetracycline in Treatment of Acne Vulgaris

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Oral ibuprofen and minocycline for the treatment of resistant acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Strategy of acne therapy with long-term antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Minocycline-induced lupus. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

The risk of liver damage associated with minocycline: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Absence of minocycline in sebum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

The assessment of acne vulgaris—the Leeds technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Tetracyclines, molecular and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

A Proposal for Structured Reporting of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Minocycline for acne. Doctors should not change the way they prescribe for acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Acute hepatitis and exfoliative dermatitis associated with minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Minocycline-induced pigmentation. Incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Side effects of minocycline: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Paper in BMJ influenced prescribing of minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Adherence to recommended medical regimens in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Side Effects of Minocycline: Different Dosage Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Dispelling myths about acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Therapy for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Pharmacokinetic studies on minocycline in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Minocycline for acne. Food reduces minocycline's bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Oral isotretinoin treatment policy. Do we all agree?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Oral isotretinoin. Where now, where next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Descriptive epidemiology of acne vulgaris in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Tetracyclines--how safe are they?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Minocycline and Lupuslike Syndrome in Acne Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

Minocycline Therapy for Acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Tetracycline and minocycline treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Patient Concepts and Misconceptions About Acne

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

pH-Partition behavior of tetracyclines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Benefit-risk assessment of acne therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Benefit-risk assessment of acne therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Minocycline: Possible vestibular side-effects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

An accurate photographic method for grading acne: initial use in a double-blind clinical comparison of minocycline and tetracycline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Absorption of minocycline hydrochloride and tetracycline hydrochloride. Effect of food, milk, and iron

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Azithromycin for the treatment of acne

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Skin cancers in transplant patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Safety of long-term high-dose minocycline in the treatment of acne

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

A comparison of doxycycline and minocycline in the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Dental and oral discolorations associated with minocycline and other tetracycline analogs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Why and when the treatment of acne fails. What to do

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Isotretinoin versus minocycline in cystic acne: a study of lipid metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

A general practice study investigating the effect of Minocin 50 mg b.d. for 12 weeks in the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002086

7 January 2021

10.1002/14651858.CD002086

Identifiers

DOI

1 reference

30 July 2017

1 reference